Skip to main content
Log in

TPMT genotyping before mercaptopurine cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. van den Akker-van Marle ME, Gurwitz D, Detmar SB, Enzing CM, Hopkins MM, Gutierrez de Mesa E, Ibarreta D.Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe. Pharmacogenomics 7: 783-792, No. 5, Jul 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

TPMT genotyping before mercaptopurine cost effective. Pharmacoecon. Outcomes News 511, 3 (2006). https://doi.org/10.2165/00151234-200605110-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605110-00007

Keywords

Navigation